| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.71 | 0.006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |